Phase 1 Dose Escalation and PK Study of Cu(II)ATSM in ALS/MND

NCT02870634 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis
Motor Neuron Disease

Interventions

DRUG: Cu(II)ATSM

Sponsor

Collaborative Medicinal Development Pty Limited